Proteinase inhibitors - IBC's Third International Conference. New approaches, new discoveries, new targets.
Durrance
Anna
A
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. anna.durrance@thomson.com
D000544:Alzheimer Disease / Q000188:drug therapy / Q000201:enzymology; D053829:Amyloid Precursor Protein Secretases; D000818:Animals; D016282:Aspartic Acid Endopeptidases; D001897:Boronic Acids / Q000494:pharmacology; D000069286:Bortezomib; D002403:Cathepsins / Q000037:antagonists & inhibitors; D004353:Drug Evaluation, Preclinical; D010450:Endopeptidases / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D019151:Peptide Library; D011480:Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D011719:Pyrazines / Q000494:pharmacology
D001897:Boronic Acids; D019151:Peptide Library; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D053829:Amyloid Precursor Protein Secretases; D002403:Cathepsins; D010450:Endopeptidases; D016282:Aspartic Acid Endopeptidases; C509280:BACE1 protein, human